Literature DB >> 29596586

A new strategy to decrease cardiac injury in aged heart following ischaemia-reperfusion: enhancement of the interaction between AMPK and SIRT1.

Qun Chen1, Edward J Lesnefsky1,2,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29596586      PMCID： PMC5909644          DOI： 10.1093/cvr/cvy062

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  13 in total

1.  Cardiomyocyte-specific deletion of Sirt1 gene sensitizes myocardium to ischaemia and reperfusion injury.

Authors:  Lin Wang; Nanhu Quan; Wanqing Sun; Xu Chen; Courtney Cates; Thomas Rousselle; Xinchun Zhou; Xuezhong Zhao; Ji Li
Journal:  Cardiovasc Res       Date:  2018-05-01       Impact factor: 10.787

2.  Activating SIRT1: a new strategy to prevent atherosclerosis?

Authors:  Ralf P Brandes
Journal:  Cardiovasc Res       Date:  2008-09-10       Impact factor: 10.787

3.  The regulation of AMP-activated protein kinase by phosphorylation.

Authors:  S C Stein; A Woods; N A Jones; M D Davison; D Carling
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

Review 4.  Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization?

Authors:  Stephen C Kolwicz; Rong Tian
Journal:  Trends Cardiovasc Med       Date:  2009-08       Impact factor: 6.677

Review 5.  Mitochondrial Metabolism in Aging Heart.

Authors:  Edward J Lesnefsky; Qun Chen; Charles L Hoppel
Journal:  Circ Res       Date:  2016-05-13       Impact factor: 17.367

6.  Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience.

Authors:  E J Lesnefsky; C F Lundergan; J M Hodgson; R Nair; J S Reiner; S W Greenhouse; R M Califf; A M Ross
Journal:  J Am Coll Cardiol       Date:  1996-08       Impact factor: 24.094

7.  Activation of the AMPK/Sirt1 pathway by a leucine-metformin combination increases insulin sensitivity in skeletal muscle, and stimulates glucose and lipid metabolism and increases life span in Caenorhabditis elegans.

Authors:  Jheelam Banerjee; Antje Bruckbauer; Michael B Zemel
Journal:  Metabolism       Date:  2016-07-09       Impact factor: 8.694

8.  Chronic metformin associated cardioprotection against infarction: not just a glucose lowering phenomenon.

Authors:  Hannah J Whittington; Andrew R Hall; Catarina P McLaughlin; Derek J Hausenloy; Derek M Yellon; Mihaela M Mocanu
Journal:  Cardiovasc Drugs Ther       Date:  2013-02       Impact factor: 3.727

9.  Sestrin2 prevents age-related intolerance to post myocardial infarction via AMPK/PGC-1α pathway.

Authors:  Nanhu Quan; Lin Wang; Xu Chen; Chelsea Luckett; Courtney Cates; Thomas Rousselle; Yang Zheng; Ji Li
Journal:  J Mol Cell Cardiol       Date:  2018-01-08       Impact factor: 5.000

10.  Sestrin2 promotes LKB1-mediated AMPK activation in the ischemic heart.

Authors:  Alex Morrison; Li Chen; Jinli Wang; Ming Zhang; Hui Yang; Yina Ma; Andrei Budanov; Jun Hee Lee; Michael Karin; Ji Li
Journal:  FASEB J       Date:  2014-11-03       Impact factor: 5.191
View more
  4 in total

Review 1.  Research Progress on Alzheimer's Disease and Resveratrol.

Authors:  Yan Yan; Huihuang Yang; Yuxun Xie; Yuanlin Ding; Danli Kong; Haibing Yu
Journal:  Neurochem Res       Date:  2020-03-11       Impact factor: 3.996

2.  Energy metabolism homeostasis in cardiovascular diseases.

Authors:  Lu-Yun Wang; Chen Chen
Journal:  J Geriatr Cardiol       Date:  2021-12-28       Impact factor: 3.327

3.  Exendin-4 Protects Against Myocardial Ischemia-Reperfusion Injury by Upregulation of SIRT1 and SIRT3 and Activation of AMPK.

Authors:  Refaat A Eid; Mashael Mohammed Bin-Meferij; Attalla Farag El-Kott; Samy M Eleawa; Mohamed Samir Ahmed Zaki; Mubarak Al-Shraim; Fahmy El-Sayed; Muhammad Alaa Eldeen; Mahmoud A Alkhateeb; Samah A Alharbi; Hussain Aldera; Mohammad A Khalil
Journal:  J Cardiovasc Transl Res       Date:  2020-04-01       Impact factor: 4.132

4.  miR‑320‑3p is involved in morphine pre‑conditioning to protect rat cardiomyocytes from ischemia/reperfusion injury through targeting Akt3.

Authors:  Lan Cao; Shijun Chai
Journal:  Mol Med Rep       Date:  2020-05-27       Impact factor: 2.952
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.